Newsroom

CathNova receives CHF 40,000 from Venture Kick to advance neuromodulation therapy toward clinical validation

01.05.2026

CathNova receives CHF 40,000 from Venture Kick to advance its neuromodulation therapy for preventing ventilator-associated pneumon ... more

omenic receives CHF 40,000 from Venture Kick to enhance AI-powered operational decision systems

01.05.2026

omenic receives CHF 40,000 from Venture Kick to advance its AI-powered decision engine for weather-sensitive industries. By simula ... more

ALP Bio raises USD 2.2M pre-seed to address immunogenicity risk in antibody development

30.04.2026

Swiss biotech startup ALP Bio has raised USD 2.2 million in pre-seed financing to advance its platform combining human immune orga ... more

more

Media contacts

For media enquiries, please email our communications team. If you have a general question about Venture Kick please visit our about us page.

Learn more about Venture Kick or download the latest annual report for detailed information.